TAILIEUCHUNG - Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: The PREDICT study

Patients with pathogenic sequence variants (PSVs) in BRCA1/BRCA2 are at high risk of developing ovarian cancer (OC). However, genetic testing for BRCA1/BRCA2 PSVs is still not a routine practice in the Middle East. With the lack of epidemiological studies in the region, we aim to describe the prevalence of BRCA1/BRCA2 PSVs in patients with OC across diferent countries in the Gulf region. | Azribi et al. BMC Cancer 2021 21 1350 https s12885-021-09094-8 RESEARCH Open Access Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region the PREDICT study Fathi Azribi1 Ehab Abdou2 Emad Dawoud1 Mohamed Ashour2 Amgad Kamal3 Mohamed Al Sayed3 and Ikram Burney4 Abstract Background Patients with pathogenic sequence variants PSVs in BRCA1 BRCA2 are at high risk of developing ovar- ian cancer OC . However genetic testing for BRCA1 BRCA2 PSVs is still not a routine practice in the Middle East. With the lack of epidemiological studies in the region we aim to describe the prevalence of BRCA1 BRCA2 PSVs in patients with OC across different countries in the Gulf region. Methods The PREDICT study was an observational prospective epidemiological study which consecutively recruited women with ovarian primary peritoneal and fallopian tube cancers from the following Gulf countries over the period from July 2017 to July 2019 United Arab Emirates UAE Kuwait and Oman. The study was approved by the local ethics committee of participating centers. The BRCA1 BRCA2 PSVs were assessed by tissue genetic testing using next-generation sequencing NGS . Results A total of 105 women were included with a median age at diagnosis of 52 years IQR . Nearly of patients reported a family history of ovarian or breast cancer while of patients reported a family history of other cancers. Most of the patients had advanced disease FIGO stage III IV at presentation. Eighty-eight patients 84 were successfully tested for somatic BRCA1 BRCA2 PSVs. Fifteen patients 17 were found to have PSVs in either BRCA1 BRCA2 or both genes of them 10 patients had BRCA1 somatic PSVs alone eight patients had BRCA2 somatic PSVs while three patients had both PSVs. Five patients with BRCA1 BRCA2 somatic PSVs had germline PSVs tests and three of them tested positive. Concerning treatment of patients received perioperative

• Y khoa - Dược
• BMC Cancer
• Gynaecological oncology
• Cancer genetics
• Next generation sequencing
• Pathogenic sequence variants
• Cancer patient pathways
• Colorectal cancer
• Lung cancer
• Breast cancer
• Prostate cancer
• Ovarian cancer
• Cancer detection
• Ovarian cancer symptoms
• Ovarian cancer signs
• Ovarian cancer tests
• Cancer biomarkers
• Pediatric cancer
• Familial cancer predisposition
• Hereditary cancer syndrome
• Genetic cancer susceptibility
• Advanced cancer
• Biliary tract cancer
• Multimodal intervention
• Pancreatic cancer
• Physical activity
• Breast cancer screening
• Familial breast cancer
• Young breast cancer survivors
• High risk relatives
• Randomized trial
• Childhood cancer
• Childhood cancer survivor
• Thyroid cancer screening
• Secondary cancer
• Cancer screening
• Community awareness
• Cancer education
• Cervical cancer
• Prior cancer
• Cancer survivors
• Cancer registry
• Second cancer
• Surgical oncology
• Cancer imaging
• Radiation oncologists
• Medical oncologists
• Oesophagogastric cancer
• Liver cancer
• Hepatobiliary cancer
• Multidisciplinary rehabilitation
• EGFR mutation
• Family history of cancer
• Inherited susceptibility
• Cancer predisposition genes
• Lung cancer aetiology
• Cancer stem cells
• Oct4 overexpressing lung cancer
• Human lung cancer xenograft model
• Disease free survivals
• Cancer hallmarks
• Cancer genesis
• Defiant disease
• Mutational signature
• Cancer diagnosis
• Cancer genomics
• Molecular medicine
• Whole genome sequencing
• Cancer susceptibility gene
• Breast cancer prognosis
• Quality of care
• Quality indicators
• Shifting cancer care
• German cancer society
• Colorectal cancer screening
• Stomach cancer screening
• Lung cancer survivor
• Physician recommendation
• Total number of lymph nodes
• Lymph node ratio
• Left colon cancer
• Right colon cancer
• Overall survival
• Cumulative incidence
• Esophageal cancer
• Head and neck cancer
• Metachronous cancer
• Young onset
• Reproductive cancer
• Risk factor
• Early detection of cancer
• Gastric cancer incidence
• Population based specialized registry
• Gastric cancer survival
• Gastric cancer clinical characteristics
• Gastric cancer pathological characteristics
• Lung Cancer Screening
• Racial disparities
• Lung Cancer diagnosis
• Screening adherence
• Second primary colorectal cancer
• Standardized incidence ratio
• Left sided colon cancer
• Right sided colon cancer
• Quality of cancer care
• Population based study